Yannick Devaud
CEO
KOVE
KOVE medical AG develops a device that seals the fetal membranes after fetoscopic interventions, preventing iatrogenic premature rupture and reducing the preterm birth rate. By utilizing the existing catheter as the entry site, the device eliminates the need for an additional puncture, allowing for quick application in under two minutes.
- Biotechnology
- Healthcare Technology
- Medical Devices
Updated 23 months ago
Funding
Raised to date
$2.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Fetoscopic interventions, while vital for treating fetal conditions, carry a risk of iatrogenic premature rupture of membranes (iPROM) due to the necessary puncture, potentially leading to preterm birth. Current methods to mitigate this risk may require additional punctures or prolonged procedure times.
Solution
KOVE medical AG offers a device designed to seal fetal membranes following fetoscopic procedures, thereby reducing the incidence of iatrogenic premature rupture of membranes and subsequent preterm birth. The device utilizes the existing catheter entry site from the fetoscopic intervention, eliminating the need for an additional puncture. This approach allows for rapid deployment, minimizing any increase in overall procedure time. By sealing the membrane defect, the device aims to restore the integrity of the amniotic sac and improve fetal outcomes.
Target Audience
The primary target audience includes fetal surgeons and maternal-fetal medicine specialists performing fetoscopic procedures.
Features
- Membrane sealant delivered through the existing fetoscope catheter.
- Rapid deployment in under two minutes.
- Biocompatible sealing material.
- Minimally invasive approach, avoiding additional punctures.